Subscribe today!
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
Regulatory & Industry
All Research Areas
News
Discovery Insider
Content
Content
Webinars
eBooks
Infographics
Videos
Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
Magazine
All Content
Research Areas
Research Areas
Neuroscience
Cancer Research
Immunology
Infectious Disease & Vaccines
Hematology
Ophthalmology
Rare & Genetic Diseases
Dermatology
Internal Medicine
Metabolic Disease
Tools & Techniques
Regulatory & Industry
All Research Areas
News
Discovery Insider
Content
Content
Webinars
eBooks
Infographics
Videos
Articles
Industry Perspectives
Compendiums
Whitepapers
Application Notes
Magazine
All Content
Subscribe!
Subscribe Today!
Home
/
Tags
/
bivalirudin
bivalirudin
| 4 min read
By
Samantha Borje
Synthetic DNA provides a safer blood clot treatment
New potential drug candidates made entirely of synthetic DNA may outperform current available blood clot treatments and avoid the adverse effects
.
News
Page 1 of 1 - 1 Total Items
1
Subscribe to our eNewsletters
Stay connected with all of the latest from Drug Discovery News.
Subscribe
Sponsored
How to choose the right fluorochromes for complex flow cytometry panels
Compare fluorochromes based on resolution, spillover, antigen expression, and other factors that can affect panel performance.
Whitepaper
Technology Guide: High-content analysis in modern drug discovery
As researchers embrace more complex cellular models, high-content analysis brings new opportunities and challenges to drug discovery.
Technology Guides
Mapping degrader activity and selectivity in intact cells
Explore how cereblon allostery and cellular target engagement profiling can reveal the mechanisms and selectivity underlying degrader activity.
Webinars